Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia

• Othman Al-Sawaf,
• Can Zhang,
• Hyun Yong Jin,
• Sandra Robrecht,
• Yoonha Choi,
• Sandhya Balasubramanian,
• Alex Kotak,
• Yi Meng Chang,
• Anna Maria Fink,
• Eugen Tausch,
• Christof Schneider,
• Matthias Ritgen,
• Karl-Anton Kreuzer,
• Brenda Chyla,
• Joseph N. Paulson,
• Christian P. Pallasch,
• Lukas P. Frenzel,
• Martin Peifer,
• Barbara Eichhorst,
• Stephan Stilgenbauer,
• Yanwen Jiang,
• Michael Hallek,
• Kirsten Fischer

Affiliations

Othman Al-Sawaf

Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne

Can Zhang

Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne

Hyun Yong Jin

Genentech Inc.

Sandra Robrecht

Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne

Yoonha Choi

Genentech Inc.

Sandhya Balasubramanian

Genentech Inc.

Alex Kotak

Roche Products Ltd

Yi Meng Chang

Hoffmann-la Roche

Anna Maria Fink

Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne

Eugen Tausch

Department III of Internal Medicine, Ulm University

Christof Schneider

Department III of Internal Medicine, Ulm University

Matthias Ritgen

Department II of Internal Medicine, University of Schleswig Holstein

Karl-Anton Kreuzer

Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne

Brenda Chyla

AbbVie Inc.

Joseph N. Paulson

Genentech Inc.

Christian P. Pallasch

Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne

Lukas P. Frenzel

Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne

Martin Peifer

Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, University of Cologne

Barbara Eichhorst

Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne

Stephan Stilgenbauer

Department III of Internal Medicine, Ulm University

Yanwen Jiang

Genentech Inc.

Michael Hallek

Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne

Kirsten Fischer

Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne